Solid Biosciences Llc Stock In The News

SLDB Stock  USD 13.82  0.43  3.02%   
The tone or emotional content of news articles related to Solid Biosciences can affect its prices. Positive news sentiment can lead to an increase in demand for Solid Biosciences' stock, while negative news sentiment can lead to a decrease in demand. Our overall analysis of Solid Biosciences' news coverage and content from conventional and social sources shows investors' bearish mood towards Solid Biosciences LLC. The specific impact of Solid Biosciences news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Solid Biosciences' overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Solid Biosciences headlines in addition to utilizing other, more conventional financial analysis modules. Check out Solid Biosciences Backtesting and Solid Biosciences Hype Analysis.

Solid Biosciences Today Top News and Investor Outlook

Yahoo News
14 Stocks With Heavy Insider Buying In 2024
https://finance.yahoo.com/news/14-stocks-heavy-insider-buying-080208688.html
 Bullish
Yahoo News
Biotech Stock Roundup: VRTX/CRSP Gene Therapy Label Expansion, ALLK Falls on Update
https://finance.yahoo.com/news/biotech-stock-roundup-vrtx-crsp-152100847.html
 Bullish
Yahoo News
Solid Biosciences' (SLDB) DMD Drug Gets Orphan Tag, Stock Up
https://finance.yahoo.com/news/solid-biosciences-sldb-dmd-drug-162700898.html
 Bullish
Yahoo News
Solid Biosciences Granted FDA Orphan Drug Designation for Duchenne Muscular Dystrophy Gene Therapy Candidate SGT-003
https://finance.yahoo.com/news/solid-biosciences-granted-fda-orphan-130000297.html
 Bullish
Yahoo News
Solid Biosciences (SLDB) Rises 271% in 3 Months: Here's Why
https://finance.yahoo.com/news/solid-biosciences-sldb-rises-271-151800479.html
 Bullish
Yahoo News
Solid Biosciences Announces $109 Million Private Placement
https://finance.yahoo.com/news/solid-biosciences-announces-109-million-120900897.html
 Bullish
Yahoo News
Solid Biosciences to Participate at 42nd Annual J.P. Morgan Healthcare Conference
https://finance.yahoo.com/news/solid-biosciences-participate-42nd-annual-130000827.html
 Bullish
Yahoo News
While institutions invested in Solid Bio...
https://finance.yahoo.com/news/while-institutions-invested-solid-biosciences-141630557.html
 Bullish
Yahoo News
Solid Biosciences' (SLDB) DMD Drug Gets Fast Track Tag, Stock Up
https://finance.yahoo.com/news/solid-biosciences-sldb-dmd-drug-103700674.html
 Bullish
Yahoo News
Solid Biosciences Receives FDA Fast Track Designation for Duchenne Muscular Dystrophy Gene Therapy SGT-003
https://finance.yahoo.com/news/solid-biosciences-receives-fda-fast-130000269.html
 Bullish

Solid Biosciences LLC Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Solid and other traded companies coverage. We help investors stay connected with Solid headlines for the 28th of March to make an informed investment decision based on correlating the impacts of news items on Solid Stock performance. Please note that trading solely based on the Solid Biosciences LLC hype is not for everyone as timely availability and quick action are needed to avoid losses.
Solid Biosciences' linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Solid Biosciences LLC investors visualize upcoming and past events in order to time the market based on Solid Biosciences LLC noise-free hype analysis.
Solid Biosciences stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Solid earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Solid Biosciences that are available to investors today. That information is available publicly through Solid media outlets and privately through word of mouth or via Solid internal channels. However, regardless of the origin, that massive amount of Solid data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Solid Biosciences news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Solid Biosciences relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Solid Biosciences' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Solid Biosciences alpha.

Solid Largest EPS Surprises

Earnings surprises can significantly impact Solid Biosciences' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2023-11-08
2023-09-30-1.19-1.050.1411 
2023-08-14
2023-06-30-1.53-1.250.2818 
2022-03-14
2021-12-31-2.91-2.40.5117 
2022-04-27
2022-03-31-2.76-3.3-0.5419 
2023-05-11
2023-03-31-2.05-1.50.5526 
2021-11-03
2021-09-30-3.02-2.40.6220 
View All Earnings Estimates

Solid Biosciences Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Solid Biosciences LLC Stock. Current markets are strongly bullish. About 72% of major world exchanges and indexes are currently up. See today's market update for more information.
Google News at Macroaxis
19th of March 2024
Acquisition by Marlowe Jennifer of 90000 shares of Solid Biosciences at 7.85 subject to Ru...
at news.google.com 
Google News at Macroaxis
15th of March 2024
Do Analysts Expect Solid Biosciences Inc Stock to Rise After It Has Risen 42.95 percent in...
at news.google.com 
seekingalpha News
13th of March 2024
Solid Biosciences reports Q4 results
at seekingalpha.com 
Google News at Macroaxis
8th of March 2024
Is it Time to Dump Solid Biosciences Inc Stock After it Is Up 13.00 percent in a Week - In...
at news.google.com 
Macroaxis News
16th of February 2024
Acquisition by Tan Kevin of 85000 shares of Solid Biosciences subject to Rule 16b-3
at MacroaxisInsider 
seekingalpha News
30th of January 2024
Solid Biosciences files to sell 19.69M common shares for holders
at seekingalpha.com 
Google News at Macroaxis
17th of January 2024
Solid Biosciences DMD Drug Gets Orphan Tag, Stock Up - Zacks Investment Research
at news.google.com 
Google News at Macroaxis
11th of January 2024
Exercise or conversion by Tan Kevin of 11250 shares of Solid Biosciences subject to Rule 1...
at news.google.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Solid Biosciences in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Solid Biosciences' short interest history, or implied volatility extrapolated from Solid Biosciences options trading.
When determining whether Solid Biosciences LLC offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Solid Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Solid Biosciences Llc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Solid Biosciences Llc Stock:
Check out Solid Biosciences Backtesting and Solid Biosciences Hype Analysis.
Note that the Solid Biosciences LLC information on this page should be used as a complementary analysis to other Solid Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.

Complementary Tools for Solid Stock analysis

When running Solid Biosciences' price analysis, check to measure Solid Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Solid Biosciences is operating at the current time. Most of Solid Biosciences' value examination focuses on studying past and present price action to predict the probability of Solid Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Solid Biosciences' price. Additionally, you may evaluate how the addition of Solid Biosciences to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Is Solid Biosciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Solid Biosciences. If investors know Solid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Solid Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.83)
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.31)
Return On Equity
(0.57)
The market value of Solid Biosciences LLC is measured differently than its book value, which is the value of Solid that is recorded on the company's balance sheet. Investors also form their own opinion of Solid Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Solid Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Solid Biosciences' market value can be influenced by many factors that don't directly affect Solid Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Solid Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Solid Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Solid Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.